Research Topic

Two studies show LDL lowering significantly reduces the risk of major vascular events in older patients.

WHO finds insufficient evidence that remdesivir improves survival or other outcomes in hospitalized patients with COVID-19, regardless of disease severity.

Symptoms of fever or chills, cough and runny nose in this study (19 to 26%) were less frequent than in studies conducted in hospital settings. The authors of the study suggest that was because this was a community-based cohort and cases of disease were likely more mild than those seen in hospitals.